Skip to main content
Matthew Ferris, MD, Radiation Oncology, Baltimore, MD, University of Maryland Medical Center

MatthewJeffreyFerrisMD

Radiation Oncology Baltimore, MD

Head & Neck, Skin Cancer, Thoracic Cancer

Head/Neck/Thoracic/Skin Radiation Oncology │ Medical Director, Maryland Proton Treatment Center │ Department of Radiation Oncology, University of Maryland School of Medicine

Dr. Ferris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ferris' full profile

Already have an account?

  • Office

    Maryland Proton Treatment Center
    850 W. Baltimore St.
    Baltimore, MD 21201
    Phone+1 410-369-5200
    Fax+1 410-347-0870
  • Is this information wrong?

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineResidency, Radiation Oncology, 2014 - 2019
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 2014
  • Loyola University Maryland
    Loyola University MarylandBS, Biology, Summa Cum Laude; Business Minor; English Minor, 2006 - 2010

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2019 - 2024
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Inductee Phi Beta Kappa Society, 2009
  • Inductee Alpha Omega Alpha Honor Medical Society

Publications & Presentations

PubMed

Journal Articles

  • Targeted Sequencing and Intracranial Outcomes of Patients with Lung Adenocarcinoma Brain Metastases Treated with Radiotherapy  
    Gabriel L Sica, Matthew J Ferris, Walter J Curran, Shannon Kahn, Suresh S Ramalingam, Pretesh R Patel, Rathi N Pillai, Robert H Press, Jim Zhong, Conor E Steuer, Taofe..., Cancer

Authored Content

  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain MetastasesApril 2018
  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018
  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018

Press Mentions

  • Cancer treatment advances are helping patients and dropping death rates
    Cancer treatment advances are helping patients and dropping death ratesFebruary 17th, 2020

Professional Memberships

Hospital Affiliations